Flow resistance in carotid and middle cerebral arteries in postmenopausal women: A comparative study of tibolone and continuous combined hormone replacement therapy

Climacteric

Volumn 5, Issue 3, 2002, Pages 259-265

  Pan, H A ^a   Wang, S T ^b   Chen, C H ^a   Pai, M C ^a   Wu, M H ^a   Huang, K E ^c  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Hormone replacement therapy; Menopause; Pulsatility index; Resistance index; Tibolone

Indexed keywords

CONJUGATED ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; TIBOLONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; LIPID BLOOD LEVEL; MIDDLE CEREBRAL ARTERY; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; VASCULAR RESISTANCE;

EID: 0036392478     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/cmt.5.3.259.265     Document Type: Article

References (38)

1. Compston JE. HRT and osteoporosis. Br Med Bull 1992;48:309-44
2. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary disease: a quantitative assessment of the epidemiological evidence. Prev Med 1991;20:47-63
3. Barrett-Connor E, Laakso M. Ischaemic heart disease risk in postmenopausal women: effects of estrogen use on glucose and insulin levels. Arteriosclerosis 1990;10:531-4
4. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 1991;151:75-8
5. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentration and metabolism of plasma lipoproteins. N Engl J Med 1991;325:1196-204
6. Sacks FM, McPherson R, Walsh BW. Effects of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations. Arch Intern Med 1994;154:1106-10
7. Sorna MR, Osnago-Gadda I, Paoletti R, et al. The lowering of lipoprotein(a) induced by estrogen plus progesterone replacement therapy in postmenopausal women. Arch Intern Med 1993;153:1462-8
8. Gilbert J, Estelles A, Cano A, et al. The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal status. Am J Obstet Gynecol 1995;173:1849-54
9. The Writing Group for the Estradiol Clotting Factors Study. Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate: a 1-year, double-blind, placebo-controlled study. Thromb Haemost 1996;75:476-80
10. Bush TL, Barrett-Connor E, Cowan DK, et al. Cardiovascular mortality and non-contraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987;75:1102-9
11. Bourne T, Hillard TC, Whitehead MI, Crook D, Campbell S. Oestrogen, arterial status, and postmenopausal women. Lancet 1990;335:1470-1
12. Gangar KF, Vyas S, Whitehead M, Crook D, Meire H, Campbell S. Pulsatility index in internal carotid artery in relation to transdermal estradiol and time since menopause. Lancet 1991;338:839-42
13. Penotti M, Nencioni T, Gabrielli L, Farina M, Castiglioni E, Polvani F. Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy. Am J Obstet Gynecol 1993;169:1226-32
14. Belfort MA, Saade GR, Snabes M, et al. Hormonal status affects the activity of the cerebral vasculature. Am J Obstet Gynecol 1995;172:1273-8
15. Prelevic GM, Bartram C, Wood J, Okolo S, Ginsburg J. Comparative effects on bone mineral density of tibolone, transdermal estrogen and oral estrogen-progestogen therapy in postmenopausal women. Gynecol Endocrinol 1996;10:413-20
16. Milner MH, Sinnott MM, Cooke TM, Kelly A, McGill T, Harrison RF. A 2-year study of lipid and lipoprotein changes in postmenopausal women with tibolone and estrogen-progestin. Obstet Gynecol 1996;87:593-9
17. Cagnacci A, Mallus E, Tuveri F, Cirillo R, Setteneri AM, Melis GB. Effects of tibolone on glucose and lipid metabolism in postmenopausal women. J Clin Endocrinol Metab 1997;82:251-3
18. Farish E, Barnes JF, Rolton HA, Spowart K, Fletcher CD, Hart DM. Effects of tibolone on lipoprotein(a) and HDL sub-fractions. Maturitas 1995;20:215-19
19. The Writing Group for the Postmenopausal Estrogen/Progestin Interventions Trial. Effects of estrogen and estrogen/progestin regimens on heart disease risk factors in postmenopausal women. J Am Med Assoc 1995;273:199-208
20. Henderson BE, Ross RK, Lobo RA, Pike MC, Mack TM. Re-evaluating the role of progestogen therapy after the menopause. Fertil Steril 1988;49:9S-15S
21. Penotti M, Sironi L, Castiglioni E, et al. Blood flow in the internal carotid and middle cerebral arteries: effects of continuous oral conjugated equine estrogens administration with monthly progestogen supplementation on postmenopausal women. Menopause 1999;6:225-9
22. Gosling RG, King KH. Ultrasound angiology. In Harcus AW, Adamson L, eds. Arteries and Veins. Edinburgh: Churchill Livingstone. 1975:61
23. Grimes DA. Prevention of cardiovascular disease in women: role of the obstetrician-gynecologist. Am J Obstet Gynecol 1988;158:1662-8
24. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med 1991;325:756-62
25. Qizilbash N, Jones L, Warlow C, Mann J. Fibrinogen and lipid concentration as risk factors for transient ischaemic attacks and minor ischaemic strokes. Br Med J 1991;303:605-9
26. Austin M. Plasma triglycerides as a risk factor for coronary heart disease: the epidemiological evidence and beyond. Am J Epidemiol 1989;129:249-59
27. Gordon T, Castelli W, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. Am J Med 1977;62:707-14
28. Lipid Research Clinics Program. The Lipid Research Clinics coronary, primary prevention trial results, II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. J Am Med Assoc 1984;251:365-74
29. Al-Azzawi F, Wahab M, Habiba M, Akkad A, Mason T. Continuous combined hormone replacement therapy compared with tibolone. Obstet Gynecol 1999;93:258-64
30. Munk-Jensen N, Ulrich LG, Obel EB, Nielsen SP, Edwards D, Meinertz H. Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: effects of plasma lipoproteins in a two-year placebo-controlled trial. Am J Obstet Gynecol 1994;171:132-8
31. Lin AL, Shain SA. Estrogen-mediated cytoplasmic and nuclear distribution of rat cardiovascular estrogen receptors. Arteriosclerosis 1985;5:668-77
32. Gislard V, Millar V, Van Houte P. Effects of 17β-oestradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 1988;244:19-22
33. Penotti M, Farina M, Castiglioni E, et al. Alteration in the pulsatility index values of the internal carotid and middle cerebral arteries after suspension of postmenopausal hormone replacement therapy: a randomized crossover study. Am J Obstet Gynecol 1996;175:606-11
34. Doren M, Rubig A, Coelingh Bennink HJ, Holzgreve W. Resistance of pelvic arteries and plasma lipids in postmenopausal women: a comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. Am J Obstet Gynecol 2000;183:575-82
35. Collins P, Rosano GM, Jiang C, Linsay D, Sarrel PM, Poole-Wilson PA. Cardiovascular protection by estrogen - a calcium antagonist effect. Lancet 1993;341:1264-5
36. Padwick ML, Whitehead M, Coffer A, King R. Demonstration of an estrogen receptor-related protein in female tissue. In Studd JWW, Whitehead MI, eds. The Menopause. Oxford: Blackwell Science, 1988:227-33
37. Penotti M, Sironi L, Miglierina L, et al. The effect of tamoxifen and transdermal 17β-estradiol on cerebral arterial vessels: a randomized controlled study. Am J Obstet Gynecol 1998; 178:801-5
38. Hillard TC, Bourne TH, Whitehead MI, Crayford TB, Collins WP, Campbell S. Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women. Fertil Steril 1992;58:959-63